- UroToday Home
- Pelvic Health & Reconstruction
The Latest Research in Overactive Bladder
Recent Abstracts
-
Effect of mirabegron on cognitive function in elderly patients with overactive bladder: MoCA results from a phase 4 randomized, placebo-controlled study (PILLAR).Overactive BladderMarch 23, 2020
-
A pilot study to investigate the associations of urinary concentrations of urinary NO, ATP and derivatives with overactive bladder symptom severity.Overactive BladderMarch 23, 2020
-
Quality of life and treatment persistence evaluation in Spanish patients treated with mirabegron. Results of the BELIEVE study.Overactive BladderMarch 23, 2020
-
Effects of Treating an Overactive Urinary Bladder in Patients with Multiple Sclerosis.Overactive BladderMarch 23, 2020
-
Transcutaneous Electrical Spinal Cord Neuromodulator (TESCoN) Improves Symptoms of Overactive Bladder.Overactive BladderMarch 16, 2020
-
International Phase III, Randomized, Double-Blind, Placebo- and Active-Controlled Study to Evaluate the Safety and Efficacy of Vibegron in Patients with Symptoms of Overactive Bladder: EMPOWUR.Overactive BladderMarch 15, 2020
-
Combination drug therapy against OAB normalizes micturition parameters and increases the release of nitric oxide during chemically induced cystitis.Overactive BladderMarch 15, 2020
-
Urovant Sciences Announces U.S. FDA Acceptance of New Drug Application for Vibegron for the Treatment of Overactive BladderOveractive BladderMarch 10, 2020
-
8 versus 12 weeks of percutaneous tibial nerve stimulation and response predictors for overactive bladder.Overactive BladderMarch 9, 2020
-
Efficacy of vibegron, a novel β3-adrenoreceptor agonist, on severe urgency urinary incontinence related to overactive bladder: post hoc analysis of a randomized, placebo-controlled, double-blind, comparative phase 3 study.Overactive BladderMarch 8, 2020
Beyond the Abstracts
-
New Participant Stratification and Combination of Urinary Biomarkers and Confounders Could Improve Diagnostic Accuracy for Overactive Bladder - Beyond the AbstractOveractive BladderMarch 5, 2020
-
Racial and Ethnic Differences in Urodynamic Parameters in Women With Overactive Bladder Symptoms - Beyond the AbstractOveractive BladderFebruary 18, 2020
-
Patient Navigation for Overactive Bladder Improves Access to Care - Beyond the AbstractOveractive BladderJanuary 23, 2020
-
A Preliminary Study on the Impact of Detrusor Overactivity on the Efficacy of Selective Bladder Denervation for the Treatment of Female Refractory Overactive Bladder - Beyond the AbstractOveractive BladderJanuary 21, 2020
-
Women with Overactive Bladder Exhibit More Unhealthy Toileting Behaviors: a Cross-Sectional Study - Beyond the AbstractOveractive BladderJanuary 9, 2020
-
A Prospective Study to Evaluate Efficacy Using the Nuro™ Percutaneous Tibial Neuromodulation System in Drug-Naïve Patients with Overactive Bladder Syndrome - Beyond the AbstractOveractive BladderJuly 28, 2019
-
Vibegron (RVT-901/MK-4618/KRP-114V) Administered Once Daily as Monotherapy or Concomitantly with Tolterodine in Patients with an Overactive Bladder - Beyond the AbstractOveractive BladderJuly 12, 2019
-
A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment - Beyond the AbstractOveractive BladderMay 14, 2019
-
Abdominal versus Standard Placement of the Sacral Nerve Stimulator Implantable Pulse Generator - Beyond the AbstractOveractive BladderMarch 7, 2019
-
A Prospective, non-intErventional Registry Study of PatiEnts initiating a Course of drug Therapy for overactIVE bladder (PERSPECTIVE): Rationale, Design, and Methodology– Beyond the AbstractOveractive BladderJune 11, 2018